Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.4 million.

  • MDxHealth's Free Cash Flow rose 5955.46% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year increase of 5647.59%. This contributed to the annual value of -$55.1 million for FY2024, which is 8322.14% down from last year.
  • According to the latest figures from Q3 2025, MDxHealth's Free Cash Flow is -$2.4 million, which was up 5955.46% from -$1.6 million recorded in Q2 2025.
  • MDxHealth's Free Cash Flow's 5-year high stood at $25.2 million during Q2 2022, with a 5-year trough of -$17.7 million in Q2 2023.
  • In the last 5 years, MDxHealth's Free Cash Flow had a median value of -$6.3 million in 2023 and averaged -$2.9 million.
  • Data for MDxHealth's Free Cash Flow shows a peak YoY increase of 21967.33% (in 2023) and a maximum YoY decrease of 17027.98% (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows MDxHealth's Free Cash Flow stood at -$7.0 million in 2021, then dropped by 27.74% to -$8.9 million in 2022, then increased by 29.52% to -$6.3 million in 2023, then dropped by 7.71% to -$6.8 million in 2024, then skyrocketed by 64.97% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$1.6 million for Q2 2025, and $5.1 million during Q1 2025.